SOPHiA GENETICS SA·4

May 20, 4:03 PM ET

Muken Ross 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) President Muken Ross Sells 761 Shares

What Happened Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 761 shares on 2026-05-19 in open-market transactions. The weighted-average price reported was $4.60 per share (range $4.54–$4.66), for a total proceeds of $3,501. The filing indicates these sales were to satisfy tax withholding obligations related to RSUs and were executed under a pre-established Rule 10b5-1(c) plan (not discretionary).

Key Details

  • Transaction date: 2026-05-19 (Form 4 filed 2026-05-20). Filing appears timely.
  • Transaction type/code: Sale (S); open-market sale to cover tax withholding (F = tax withholding).
  • Shares sold: 761; weighted-average price: $4.60; price range: $4.54–$4.66.
  • Total proceeds: $3,501.
  • Footnotes: F1 — sale to satisfy tax withholding from RSU vesting on 2026-05-18; F2 — weighted average price with per-trade price range, and availability of per-price breakdown on written request.
  • Shares owned after transaction: Not specified in this filing.

Context These sales were executed pursuant to a pre-established 10b5-1 trading plan to cover withholding for vested restricted stock units, which is a routine administrative transaction and not an open-market discretionary sell signal. Retail investors should view this as tax-related selling rather than an explicit change in insider sentiment.